Tempest Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TPST and other ETFs, options, and stocks.

About TPST

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients. 

CEO
Matthew Angel
CEOMatthew Angel
Employees
4
Employees4
Headquarters
Brisbane, California
HeadquartersBrisbane, California
Founded
2011
Founded2011
Employees
4
Employees4

TPST Key Statistics

Market cap
15.56M
Market cap15.56M
Price-Earnings ratio
-0.22
Price-Earnings ratio-0.22
Dividend yield
Dividend yield
Average volume
14.56M
Average volume14.56M
High today
$1.09
High today$1.09
Low today
$0.8134
Low today$0.8134
Open price
$0.86
Open price$0.86
Volume
4.80M
Volume4.80M
52 Week high
$12.23
52 Week high$12.23
52 Week low
$0.7432
52 Week low$0.7432

Stock Snapshot

As of today, Tempest Therapeutics(TPST) shares are valued at $0.95. The company's market cap stands at 15.56M, with a P/E ratio of -0.22.

During the trading session on 2026-09-20, Tempest Therapeutics(TPST) shares reached a daily high of $1.09 and a low of $0.81. At a current price of $0.95, the stock is +17.0% higher than the low and still -12.7% under the high.

Trading volume for Tempest Therapeutics(TPST) stock has reached 4.8M, versus its average volume of 14.56M.

Over the past 52 weeks, Tempest Therapeutics(TPST) stock has traded between a high of $12.23 and a low of $0.74.

Over the past 52 weeks, Tempest Therapeutics(TPST) stock has traded between a high of $12.23 and a low of $0.74.

TPST News

TipRanks 3d
Tempest Therapeutics Expands In Vivo CAR-T Collaboration

Tempest Therapeutics ( (TPST) ) has provided an update. On September 14, 2026, Tempest Therapeutics entered an exclusive collaboration, option and license agre...

TipRanks 4d
Tempest Therapeutics Adjourns Meeting on Governance Changes

An announcement from Tempest Therapeutics ( (TPST) ) is now available. On September 15, 2026, Tempest Therapeutics reconvened a special shareholder meeting ori...

Benzinga 4d
Tempest Therapeutics Stock Surges Wednesday: What's Driving the Action?

Shares of Tempest Therapeutics Inc (NASDAQ:TPST) are trading sharply higher Wednesday morning as investors respond positively to a strategic agreement expanding...

Tempest Therapeutics Stock Surges Wednesday: What's Driving the Action?

More TPST News

Benzinga 5d
Tempest Therapeutics Stock Climbs Over 66% After Hours: Here's Why

Tempest Therapeutics, Inc. (NASDAQ:TPST) shares soared 66.53% to $1.26 in after-hours trading on Tuesday after the California-based clinical-stage biotechnology...

Tempest Therapeutics Stock Climbs Over 66% After Hours: Here's Why
TipRanks 5d
Tempest Therapeutics Announces New Private Warrant Financing

The latest update is out from Tempest Therapeutics ( (TPST) ). On September 11, 2026, Tempest Therapeutics entered into a securities purchase agreement with an...

People also own

Based on the portfolios of people who own TPST. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.